Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
71%
OVERLAP
BY WEIGHT
60
# OF OVERLAPPING
HOLDINGS
FHLC
334
HOLDINGS
20%
ALSO IN IXJ
IXJ
114
HOLDINGS
54%
ALSO IN FHLC
SECTOR DRIFT (FHLC minus IXJ)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in IXJ |
Overlap | |
|---|---|---|---|---|
| ELI LILLY & CO | 13.0% | 10.5% | 10.5% | |
| JOHNSON & JOHNSON | 7.5% | 6.1% | 6.1% | |
| ABBVIE INC | 6.1% | 4.8% | 4.8% | |
| UNITEDHEALTH GROUP INC | 4.5% | 3.9% | 3.9% | |
| MERCK & CO. INC. | 4.0% | 3.4% | 3.4% | |
FHLC Overweight Relative to IXJ
| ELI LILLY & CO | 2.6% | |
| JOHNSON & JOHNSON | 1.4% | |
| ABBVIE INC | 1.3% | |
| ALNYLAM PHARMACEUTICALS INC | 0.8% | |
| UNITEDHEALTH GROUP INC | 0.6% | |
| ABBOTT LABORATORIES | 0.6% | |
| MERCK & CO. INC. | 0.6% | |
| INSMED INC | 0.5% | |
| VEEVA SYSTEMS INC-CLASS A | 0.5% | |
| INTUITIVE SURGICAL INC | 0.5% |
FHLC Underweight Relative to IXJ
| ROCHE HOLDING LTD | -3.7% | |
| ASTRAZENECA PLC | -3.6% | |
| NOVARTIS AG | -3.4% | |
| NOVO NORDISK A/S-B | -2.3% | |
| SANOFI-AVENTIS | -1.3% | |
| GSK PLC | -1.3% | |
| ESSILOR INTERNATIONAL | -1.2% | |
| CSL LIMITED | -0.7% | |
| HOYA CORP | -0.7% | |
| TAKEDA PHARMACEUTICAL CO LTD | -0.6% |